Natural Products from Marine Fungi for the treatment of cancer


The MarineFungi consortium demonstrated the sustainable exploitation of marine natural resources providing appropriate culture conditions. New anti cancer compounds are now  characterised to the stage of in vivo proof of concept ready to enter further drug development. Read more about our approach and background by choosing the approriate section in the pull down menue on top of the page.

We developed the technological basis for a sustainable use of marine microbial products along the added-value chain from the marine habitat to the drug candidate and process concept. Find our publications.

The project MARINE FUNGI was from May 2011-April 2014. The consortium continues the work and will use this site to share results and insights and the development of marine biotechnology. See our partners in the PARTNER menue.

Download our report.

Follow us on




Watch on EuroNews:

Deep Cure

Over 99% of the microscopic inhabitants of the world's seas have still not been scientifically studied, even though many of them might be useful to treat cancer and other human diseases. In fact, there are so many unexplored species that it is hard to even estimate how much we still do not know about them.



Article published on new method for rapid screening for natural compound production

The paper “Development and validation of a fast and optimized screening method for enhanced production of secondary metabolites using the marine Scopulariopsis brevicaulis strain LF580 producing anti-cancer active scopularide A and B” was recently published in PLOS ONE and is available online at

Article published on biotechnological production of scopularide

Released today!

MS: 1911523627123537
Title: Production of scopularide A in submerged culture with Scopulariopsis brevicaulis
Authors: Tamminen  Anu, Kramer  Annemarie, Labes  Antje, Wiebe G Marilyn,
Journal: Microbial Cell Factories


Showing 4 - 6 of 79 results.
Items per Page 3
of 27